Physician profile
Joseph D Landers
NPI 1356358485
$1,314.09
in general payments reported to CMS, 2019-2025
13 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $92.57 · 2021: $305 · 2022: $191 · 2023: $240 · 2024: $132 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $452.11 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $310.24 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $149.36 | 2021 | |
| Vifor Pharma, INC. | $124.63 | 2019-2021 | |
| Medtronic, INC. | $77.36 | 2025 | Protege Rx |
| Astrazeneca Pharmaceuticals LP | $55.11 | 2022-2024 | Farxiga |
| Glaxosmithkline, LLC. | $50.69 | 2022-2023 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $18.78 | 2024 | |
| Paratek Pharmaceuticals, INC. | $17.88 | 2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $16.32 | 2022 | |
| Mylan Specialty L.P. | $15.60 | 2023 | Yupelri |
| Kestra Medical Technology Services, INC. | $13.57 | 2024 | Assure Wcd |
| Allergan, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Landers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.